Prions: in[PSI]t from Yeast
This paper was written for BIO324 Molecular Neuroscience. In this assignment, Jennifer McGuire role-played a noted cell biologist, Susan L. Lindquist, and wrote a state–of-the-art review article on Dr. Lindquist’s research field, as is she were Dr. Lindquist herself. She then presented a PowerPoint seminar as Dr. Lindquist in an annual public student research conference “NeuroFrontiers” held at Lake Forest College.
Summary
Prions, responsible for such neurodegenerative diseases as mad-cow disease and scrapie, are proteins that transmit a trait without the use of conventional genetic material (DNA or RNA). Prions’ infectivity arises from their tendency to adopt an altered conformation that induces the normally folded prion protein to change its shape as well. My lab started out studying yeast protein chaperones, which help proteins fold properly or, in the event of environmental stress, refold properly. One chaperone, Hsp104, has the unique role of breaking up protein aggregates. The discovery that Hsp104 mediates a yeast phenotype, called [PSI+], that shows a prion-like pattern of inheritance altered the course of my work dramatically. My lab has since found that [PSI+] arises from the altered conformation of a translation termination factor, Sup35, resulting in insoluble aggregates. Paradoxically, either deletion or overexpression of Hsp104 abolishes [PSI+]. One of our more astounding findings was that whereas mammalian prions are harmful, yeast prions can be beneficial. In one fungus, prions are even essential for survival during part of its life cycle. Thus, in addition to providing a simple system in which to study prion genetics, yeast has broadened our view of prion function overall.
Introduction
Prions were first discovered as the infectious agents responsible for such neurogenerative diseases as scrapie, mad cow disease, and Creuzfeldt-Jakob disease1. They incited immediate interest and controversy since they appeared to pass on the disease phenotype without the use of DNA or RNA, henceforth considered the only molecules capable of passing on a trait.
The prion hypothesis, set forth by Stanley Prusiner, states that prions propogate themselves via a protein-only mechanism in which prion protein of an altered conformation induces normally folded proteins to adopt the prion form1. The prion protein in mammals is called PrP and appears to be solely responsible for a host of diseases with differing pathologies.
Protein chaperones are proteins that help other proteins acquire their proper conformation2. Many chaperones are upregulated in response to such environmental stressors as heat, metals, and ethanol3, hence the common prefix Hsp (heat-shock protein). Several families of protein chaperones have been identified, including hsp110, hsp100, hsp90, hsp70, hsp60, hsp40, hsp10, and small hsp’s3. Hsp70, with the help of Hsp40, binds to proteins as they are being made by the ribosome to prevent inappropriate folding before complete protein synthesis2. Hsp60 is a barrel- shaped structure that acts to sequester misfolded proteins from other proteins, giving them a chance to refold without risk of aggregation2.
This review charts the course of my work over the past 13 years, and the remarkable turn it took when two seemingly unrelated fields collided.
A novel chaperone, a novel function
My lab started out attempting to identify and characterize protein chaperones in yeast. One question we addressed was that of thermotolerance. Although yeast prefer to grow at 25°C, they are able to withstand long periods at significantly higher temperatures. Because chaperones help cells survive exposure to stressors such as heat, it seemed logical that a chaperone would be responsible for this thermotolerance.
We sought out the protein responsible for this thermotolerance by comparing the proteins present in yeast cells grown at 25°C and cells that had been heat shocked by growing at 39°C. In addition to a few known chaperones, one previously unidentified 104-kilodalton (kDa) protein was upregulated4. We named this protein Hsp1044.
Hsp104 is part of the highly conserved Hsp100 gene family5, homologues of which are present in bacteria, trypanosomes, plants, fungi, and mammals5,6. Its two ATP-binding sites show high similarity to the bacterial ClpA/ClpB proteases and are both essential for proper function5.
Studies on hsp104 null mutants demonstrated the many key roles that this protein plays. Hsp104 is responsible for endowing spores with their ability to withstand extreme heat7 and is essential in growing cells for what is known as induced thermotolerance. Induced thermotolerance results when cells are gradually shifted to high termperatures, versus basal thermotolerance, which is measured by shifting from normal temperatures to high temperatures directly4. Hsp104 is also upregulated in response
to ethanol and certain metals, bringing with it the predicted tolerance to high heat 7.
Compared to other known chaperones, the mechanism of Hsp104 is unique. Rather than preventing improper folding of newly made or denatured proteins, Hsp104 breaks up protein aggregates that may form when proteins denature at high heat8.
An exquisite example of form meets function, Hsp104 becomes arranged into ring-shaped hexamers in the presence of ATP 5. This shape immediately brings to mind the barrel shapes of Hsp60 and proteasomes, both of which engulf other proteins to either help them fold or digest them9.
Figure 1. The [PSI+] phenotype
In [psi-] (normal) cells, Sup35 works in conjunction with Sup45 to terminate protein translation. In [PSI+] cells, the N-termini of Sup35 aggregate, meaning there is less Sup35 available for translation termination and the ribosome reads through some stop codons. Adapted from Uptain and Lindquist (2002).
The prion connection
Two yeast factors discovered in the 60’s and 70’s, [PSI+] and [URE3], showed a strange pattern of inheritance that could not be explained until recently9. Instead of the 3:1 ratio expected from Mendelian inheritance, these factors showed a 1:1:1:1 inheritance; that is, if the parent cell displayed either of these phenotypes, all four progeny did too. One possible explanation for the [PSI+]/[URE3] phenomenon was put forth in 1994 when Reed Wickner made the brilliant suggestion that perhaps, akin to the infectivity seen in mammalian prions, these factors followed a protein-only pattern of inheritance11.
Several lines of evidence supported this hypothesis. For one, overexpression of Sup35 results in [PSI+] cells12, just as overexpression of PrP results in prion disease in mice13. For another, both of these factors are metastable, spontaneously disappearing at rates higher than expected from random mutations10. Finally, cells can be “cured” of these factors through low concentrations of guanidine hydrochloride, a protein denaturant10.
The [PSI+] phenotype results in some stop codons being read through (Fig. 1). It is the product of the Sup35 protein10, which, along with Sup45, makes up the translation termination factor14 (Fig. 1). The [URE3] phenotype causes cells to take up catabolites during nitrogen abundance that it normally takes up only during nitrogen starvation11. It is associated with the protein Ure2, which prevents transcription of a certain catabolite transporter when nitrogen is abundant10.
As described above, prions were first defined as proteins capable of a protein-only model of infectivity. Wickner’s proposal broadened this definition to include a protein-only model of inheritance while challenging the dogma that only nucleic acids can act as genetic elements.
Hsp104 and [PSI+]
The burgeoning field of yeast prions abruptly became of the utmost interest to my lab when its relationship with a now familiar member of my work, Hsp104, was revealed. The connection was made when Yury Chernoff, working in association with Bun-ichiro Ono, Sergei Inge-Vechtomov, and Susan W. Liebman, screened an S. cerevisiae genomic library for genes that modified [PSI+]. Just one clone from this library suppressed the [PSI+] phenotype: Hsp10415.
As it turns out, Hsp104’s relationship with [PSI+] is rather paradoxical: while overexpression of this chaperone makes [PSI+] cells [psi-], so does removing Hsp104 altogether15. In fact, once the plasmid bearing Hsp104 is lost, cells are unable to become [PSI+]15, demonstrating the essential role of Hsp104 in maintaining this phenotype.
Investigation of yeast prions immediately lent support for the prion hypothesis that proteins can act as genetic elements. The solubility of Sup35 correlates to whether a cell is [PSI+] or [psi-]. In [psi-] cells, most Sup35 is soluble while in [PSI+] cells, a substantial portion of the Sup35 is insoluble16. [PSI+] cells contain Sup35 aggregates in the cytosol detectable by GFP15.
That [PSI+] is caused by protein aggregates immediately makes clear the role of Hsp104 in mediating this phenotype, or at least in abrogating it upon overexpression. The need for Hsp104 in maintaining the [PSI+] is less easy to explain. One possibility is that this chaperone may convert normal Sup35 protein to a form that forms aggregates (Figure 2 and below). The insolubility of these prions bears a striking resemblance to the scrapie form of PrP, as does their resistance to proteolysis
Figure 2. A model for Sup35 conversion and assembly
In this model, an intermediate amount of Hsp104 converts soluble Sup35 to a less structured form that nucleates over time. This nucleus then rapidly seeds further conversion. Overexpression of Hsp104 resolves Sup35, eliminating [PSI+].
Fiber formation in [PSI+]
Several mammalian diseases, such as the transmissible spongiform encephalopathies, Alzheimer’s disease, and Huntington’s disease are characterized by the presence of amyloid fibers1. Amyloid fibers contain high amounts of beta sheet and can be identified by their ability to bind the dye Congo red17. The NM region of Sup35 (i.e. the prion- determining region, see below) spontaneously forms amyloid fibers in vitro17. However, “seeding” the reaction by adding a tiny amount of NM fiber greatly increases the speed with which soluble Sup35 forms fibers17. These experiments directly demonstrate the ability of aggregated proteins to “pass on” a trait to normal proteins.
Several possible models can potentially explain the mechanism of fiber formation by Sup35. However, kinetic analysis of fiber assembly supports a model called nucleated conformational conversion. In this model, less structured Sup35 slowly forms nuclei, which then rapidly seed the nucleation of other Sup35 proteins18. Hsp104 may aid in the production of less structured forms of Sup35 that are used to form nuclei18 (Figure 2).
The Sup35 prion-determining domain
Sup35 contains three domains with distinct properties. The C-terminus (C) is soluble, conserved among species, and is the only domain necessary for translation termination17. The middle domain (M) is still not well understood but appears to influence the inheritance pattern of [PSI+]19. The N-terminus (N) is insoluble, unconserved, and unessential for biological function17. Overexpression of this region results in aggregates and makes cells [PSI+]; cells with this region deleted can never be [PSI+]10. In short, N is responsible for endowing Sup35 with all of its prion-like traits.
The Sup35 N-terminus shows similarity to the N-terminus of mammalian PrP in that it contains five imperfect glutamine- and asparagine-rich oligopeptide repeats17. Expanded polyglutamine repeats in the protein huntingtin (Ht) are associated with Huntington’s disease20. Such conservation suggests that these repeats have an inherent tendency to aggregate. Indeed, removing four of the five repeats from+ Sup35 results in the inability of cells to become [PSI ] while inserting two more repeats enhances the [PSI+] phenotype21. And Sup35 containing mutations in the glutamine/asparagine-rich region greatly diminishes the prion-forming capacity of ths protein, as found by my colleague, Jonathan Weissman
We extended these findings by conducting similar experiments on Ht in both yeast and Caenorhabditis elegans. As predicted, with increasing lengths of the polyglutamine repeat of Ht, the greater the amount of insoluble Ht in the cell20, 23. In yeast, deletion of Hsp104 eliminated aggregates while in both systems, overexpression of Hsp104 reduced aggregates20, 23.
The aggregation properties of NM are such that we were able to take an unrelated protein, the glucocorticoid receptor, and turn it into a prion simply by fusing it with NM24. This experiment demonstrated that NM is sufficient for inducing a prion-like state, and provides unequivocal evidence for a protein-only mechanism of inheritance.
Peculiarities of yeast
In addition to providing strong evidence supportive of the prion hypothesis outlined by Prusiner1, yeast prions have suggested solutions to questions that are harder to address in mammals.
One of these questions surrounds the issue of strains. If prion diseases are all caused by a single protein, PrP, what can account for the different pathologies seen in many of them? In yeast, different [PSI+] strains can be distinguished based on their differing degrees of stop codon suppression. The basis for these strains lies in the efficiency with which they convert Sup35 to the prion form. Weaker strains convert Sup35 less efficiently, resulting in lower ratios of soluble to insoluble Sup35 and less stop codon suppression25.
In mammals, prions are harmful and so were at first assumed to be the consequence of an aberrant if not defective protein. In yeast, it appears that this is not always the case. [PSI+] and [psi-] yeast grown in a variety of conditions show different amounts of survival that varies according to the strain and the conditions26. For some strain-conditions combinations [PSI+] cells survive more; for others, [psi-] cells survive more; and for still others, [PSI+] state has no effect. Thus, [PSI+] can spontaneously “turn on” different phenotypes, aiding the survival of some cells and increasing the overall survival of the population in changing environments.
Prions abound
Once yeast prions and the essential features of their prion-determining domain had been identified, it was a simple matter of searching databases for proteins with similar domains. Such searches turned up several other candidate prion proteins in several species of fungus.
We were able to confirm that one of these candidates, [RNQ+], is in fact a prion: when the N- terminus of its protein-determinant Rnq1 was substituted for the N-terminus of Sup35, this recombinant Sup35 made cells [PSI+]27. The protein chaperone Sis1, part of the Hsp40 family, is necessary for maintenance of [RNQ+]28. Several other putative prions have yet to be well characterized29.
Another prion, [PIN+] ([PSI+] inducibility factor), was first identified not via homology but by its ability to substantially increase the appearance of [PSI+]29. Overexpression of both Sup35 and Rnq1 makes [pin-] cells [PIN+]29.
Another prion, [HET-s], found in the filamentous fungus Podospora anserina29, takes the finding that prions are not always harmful even farther. Whereas [PSI+] is advantageous to budding yeast under certain conditions, [HET-s] is necessary to prevent lethal fusion of mycelia of incompatible strains29.
The widespread presence and diverse roles of prions suggests that the tendency of certain proteins to misfold has frequently been exploited by cells and that the aberrant appearance of mammalian prions may be the exception rather than the rule.
Findings in mammalian prions
In the past seven years, my lab has spent some time investigating mammalian prions and their relationships to chaperones. The protein that gives rise to mammalian prions, PrP, can exist in two forms: the soluble, protease-sensitive form (PrPC), and the insoluble, protease-resistant form responsible for disease (PrP Sc, named after one of the first known prion diseases, scrapie)1. PrP is known to be a cell- surface glycoprotein that is processed through the cell secretory pathway, but its function remains a mystery30. For reasons that are still unknown, PrPSc tends to selectively accumulate in and kill neurons, even though the normal form is ubiquitous1.
A series of in vitro experiments elucidated the mechanics of PrP. We found that yeast Hsp104 interacts not only with Sup35 but with hamster PrP31. Interestingly, whereas incubation of Hsp100 proteins with a substrate normally increases their ATPase activity, Sup35, PrP, and other amyloidogenic proteins decreased Hsp104 ATPase activity31. This phenomenon suggests that Hsp104 reacts with prion- like proteins in a manner that differs from its normal chaperone function. The conversion of PrP to its insoluble state is enhanced by Hsp104 and another chaperone, GroEL32. However, in addition to chaperones, a small amount of pre-formed PrPSc is necessary32.
Part of the reason for the toxicity of misfolded PrP can be attributed to the inherent tendency of this protein to misfold and accumulate in the cytosol33. Proteins that have misfolded beyond repair in the endoplasmic reticulum are often booted out into the cytosol to be digested by proteasomes, a process called retrograde transport33 .
In strong support of a retrograde transport model, cells treated with proteasome inhibitors display an accumulation of PrP in the cytosol33. What’s more, the form of PrP that accumulates in the cytosol lacks an N-terminal ER translocation signal peptide and C- terminal GPI sequence, indicative of processing in the ER but not the Golgi33. Increasing concentrations of cytosolic PrP increases the formation of PrPSc 34 and leads to increasing toxicity in neuroblastoma cells35suggesting that an overabundance of PrP overwhelms the proteasomes, allowing PrP to spontaneously form.
Conclusion
In summary, yeast has provided a genetically tractable system in which to study the genetics of prions. Our studies have done much to support the prion hypothesis and have even extended it to include a protein-only mechanism of inheritance in addition to the protein-only mechanism of infectivity seen in mammals. Yeast have demonstrated that prions are a universal phenomenon whose functions can differ greatly.
Acknowledgement
I would like to thank Dr. Shubhik DebBurman for giving me the opportunity to audit this class and for assisting me in this project.
References
1. Prusiner SB. Biology and genetics of prion diseases. Annu Rev Microbiol. 1994;48:655-86.
2. Alberts, B. et al. (Eds.) Molecular Biology of the Cell. 2002. Garland Science: New York.
3. Martin E. Feder. Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology. Annual Review of Physiology Mar 1999, Vol. 61, pp. 243-282
4. Sanchez Y, Lindquist SL. HSP104 required for induced thermotolerance. Science. 1990 Jun 1;248(4959):1112-5.
5. Parsell DA, Sanchez Y, Stitzel JD, Lindquist S. Hsp104 is a highly conserved protein with two essential nucleotide-binding sites. Nature. 1991 Sep 19;353(6341):270-3.
6. Gottesman, S., et al. (1990). Conservation of the regulatory subunit for the Clp ATP-dependent protease in prokaryotes and eukaryotes. PNAS. 87: 3513-3517.
7. Sanchez Y, Taulien J, Borkovich KA, Lindquist S. Hsp104 is required for tolerance to many forms of stress. EMBO J. 1992 Jun;11(6):2357-64.
8. Parsell DA, Kowal AS, Lindquist S. Saccharomyces cerevisiae Hsp104 protein. Purification and characterization of ATP-induced structural changes. J Biol Chem. 1994 Feb 11;269(6):4480-7.
9. Parsell DA, Kowal AS, Singer MA, Lindquist S. Protein disaggregation mediated by heat-shock protein Hsp104. Nature. 1994 Dec 1;372(6505):475-8.
10. Lindquist S. Mad cows meet psi-chotic yeast: the expansion of the prion hypothesis. Cell. 1997 May 16;89(4):495-8.
11. Wickner RB. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science. 1994 Apr 22;264(5158):566-9.
12. Chernoff YO, Derkach IL, Inge-Vechtomov SG. Multicopy SUP35 gene induces de-novo appearance of psi-like factors in the yeast Saccharomyces cerevisiae. Curr Genet. 1993 Sep;24(3):268-70.
13. Westaway D, DeArmond SJ, Cayetano-Canlas J, Groth D, Foster D, Yang SL, Torchia M, Carlson GA, Prusiner SB. Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell. 1994 Jan 14;76(1):117- 29.
14. Stansfield I, et al. The products of the SUP45 (eRF1) and SUP35 genes interact to mediate translation termination in Saccharomyces cerevisiae. EMBO J. 1995 Sep 1;14(17):4365-73.
15. Chernoff YO, Lindquist SL, Ono B, Inge-Vechtomov SG, Liebman SW. Role of the chaperone protein Hsp104 in propagation of the yeast prion- like factor [psi+]. Science. 1995 May 12;268(5212):880-4.
16. Patino MM, Liu JJ, Glover JR, Lindquist S. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science. 1996 Aug 2;273(5275):622-6.
17. Glover JR, et al. Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. cerevisiae. Cell.
1997 May 30;89(5):811-9.
18. Serio TR, et al. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science. 2000 Aug 25;289(5483):1317-21.
19. Liu JJ, Sondheimer N, Lindquist SL. Changes in the middle region of Sup35 profoundly alter the nature of epigenetic inheritance for the yeast prion [PSI+]. Proc Natl Acad Sci U S A. 2002 Dec 10;99 Suppl 4:16446- 53.
20. Krobitsch S, Lindquist S. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc Natl Acad Sci U S A. 2000 Feb15;97(4):1589- 94.
21. Liu JJ, Lindquist S. Oligopeptide-repeat expansions modulate 'protein- only' inheritance in yeast. Nature. 1999 Aug 5;400(6744):573-6.
22. DePace AH, Santoso A, Hillner P, Weissman JS. A critical role for amino-terminal glutamine/asparagine repeats in the formation and propagation of a yeast prion. Cell. 1998 Jun 26;93(7):1241-52.
23. Satyal SH, et al. Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 2000 May 23;97(11):5750-5.
24. Li L, Lindquist S. Creating a protein-based element of inheritance. Science. 2000 Jan 28;287(5453):661-4.
25. Uptain SM, Sawicki GJ, Caughey B, Lindquist S. Strains of [PSI(+)] are distinguished by their efficiencies of prion-mediated conformational conversion. EMBO J. 2001 Nov 15;20(22):6236-45.
26. True HL, Lindquist SL. A yeast prion provides a mechanism for genetic variation and phenotypic diversity. Nature. 2000 Sep 28;407(6803):477- 83.
27. Sondheimer N, Lindquist S. Rnq1: an epigenetic modifier of protein function in yeast. Mol Cell. 2000 Jan;5(1):163-72.
28. Sondheimer N, Lopez N, Craig EA, Lindquist S. The role of Sis1 in the maintenance of the [RNQ+] prion.
EMBO J. 2001 May 15;20(10):2435-42.
29. Uptain SM, Lindquist S. Prions as protein-based genetic elements. Annu Rev Microbiol. 2002;56:703-41.
30. Harris DA, et al. Cell biology of the prion protein. Curr Top Microbiol Immunol. 1996;207:77-93.
31. Schirmer EC, Lindquist S. Interactions of the chaperone Hsp104 with yeast Sup35 and mammalian PrP. Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13932-7.
32. DebBurman SK, Raymond GJ, Caughey B, Lindquist S. Chaperone- supervised conversion of prion protein to its protease-resistant form.
Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13938-43.
33. Ma J, Lindquist S. Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):14955-60.
34. Ma J, Lindquist S. Science. Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol. 2002 Nov 29;298(5599):1785-8.
35. Ma J, Wollmann R, Lindquist S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science. 2002 Nov 29;298(5599):1781-5.